Abstract
Introduction
Hemangioblastomas are uncommon tumors of the central nervous system that can be seen in Von Hippel-Lindau (VHL) disease. Despite their benign histology, hemangioblastomas can cause substantial morbidity due to involvement of critical structures. In order to better understand the clinical behavior of spinal cord hemangioblastomas, we have analyzed the clinical, pathologic, radiologic characteristics and management of sporadic and VHL-associated cases at our institution.
Methods
We performed a database search to identify all spinal hemangioblastomas at our institution between 1997 and 2016. Tumor characteristics were analyzed for sporadic and VHL-associated tumors separately in order to understand the differences in groups.
Results
We included 20 patients with VHL-associated spinal hemangioblastomas, and 22 patients with sporadic spinal hemangioblastomas. VHL-associated patients were significantly younger at time of presentation compared to sporadic patients (p < 0.0025). Thirty-two patients (76.2%) presented with focal weakness, 34 (81.0%) with sensory loss, and 22 (52.4%) with pain. VHL patients were more likely to present with multiple symptoms (p < 0.001). Median follow-up time was 20.9 months, during which 17 tumors recurred. The median recurrence free interval was 44 months. There were no differences in gross total resection rates between sporadic and VHL-associated cases (p = 0.197). VHL-associated cases had a higher rate of repeat surgery for recurrence (14 patients-73.6%) compared to sporadic cases (3 patients-13.6%; p < 0.001).
Conclusion
VHL-associated spinal hemangioblastomas differ from sporadic tumors in terms of age, presenting symptoms, multifocality, and rate of recurrence. Recurrences seem to be unrelated to the extent of resection, indicating the need for life-long follow up for VHL patients.
Similar content being viewed by others
References
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
Maher E, Yates J, Harries R, Benjamin C, Harris R, Moore A et al (1990) Clinical features and natural history of von Hippel-Lindau disease. QJM 77(2):1151–1163
Sung DI, Chang CH, Harisiadis L (1982) Cerebellar hemangioblastomas. Cancer 49(3):553–555
Bostrom A, Hans FJ, Reinacher PC, Krings T, Burgel U, Gilsbach JM et al (2008) Intramedullary hemangioblastomas: timing of surgery, microsurgical technique and follow-up in 23 patients. Eur Spine J 17(6):882–886. https://doi.org/10.1007/s00586-008-0658-1
Deng X, Wang K, Wu L, Yang C, Yang T, Zhao L et al (2014) Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article. J Neurosurg Spine 21(2):260–269. https://doi.org/10.3171/2014.1.SPINE13866
Westwick HJ, Giguere JF, Shamji MF (2016) Incidence and prognosis of spinal hemangioblastoma: a surveillance epidemiology and end results study. Neuroepidemiology 46(1):14–23. https://doi.org/10.1159/000441147
Murota T, Symon L (1989) Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery 25(5):699–708
Yasargil M, Antic J, Laciga R, De Preux J, Fideler R, Boone S (1976) The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surgical Neurology 1976(3):141–148.
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D (2001) Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48(1):55–63
Filling-Katz M, Choyke P, Oldfield E, Charnas L, Patronas N, Glenn G et al (1991) Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41(1):41–41
Kim TY, Yoon DH, Shin HC, Kim KN, Yi S, Oh JK et al (2012) Spinal Cord Hemangioblastomas in von Hippel-Lindau disease: management of asymptomatic and symptomatic tumors. Yonsei Med J 53(6):1073–1080
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM et al (2003) von Hippel-Lindau disease. Lancet 361(9374):2059–2067. https://doi.org/10.1016/S0140-6736(03)13643-4
Neumann H, Eggert H, Scheremet R, Schumacher M, Mohadjer M, Wakhloo A et al (1992) Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol, Neurosurg Psychiatry 55(10):898–901
Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH (2003) Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98(1):106–116
Mandigo CE, Ogden AT, Angevine PD, McCormick PC (2009) Operative management of spinal hemangioblastoma. Neurosurgery 65(6):1166–1177
Böhling T, Hatva E, Minna Kujala M, Claesson-Welsh L, Alitalo K, Haltia M (1996) Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55(5):522–527
van Leeuwaarde RS, Ahmad S, Links TP, Giles RH (1993) Von Hippel-Lindau syndrome. In: Adam MP, Ardinger HH, Pagon RA, (eds.) GeneReviews((R)). Seattle
Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P (1989) Hemangioblastomas of the central nervous system: A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70(1):24–30
Kanno H, Kobayashi N, Nakanowatari S (2014) Pathological and clinical features and management of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Kidney Cancer VHL 1(4):46–55. https://doi.org/10.15586/jkcvhl.2014.12
Cristante L, Herrmann H-D (1999) Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir 141(4):333–340
Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI (2001) Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 49(2):321–328
Xu Q-W, Bao W-M, Mao R-L, Yang G-Y (1994) Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord. Neurosurgery 35(4):671–676
Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR (2010) Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease: clinical article. J Neurosurg 12(3):233–242
Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98(1):82–94
Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim E-S (2007) Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc 42(6):436–440
Takai K, Taniguchi M, Takahashi H, Usui M, Saito N (2010) Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir 50(7):560–567
Park CH, Lee CH, Hyun SJ, Jahng TA, Kim HJ, Kim KJ (2012) Surgical outcome of spinal cord hemangioblastomas. J Korean Neurosurg Soc 52(3):221–227. https://doi.org/10.3340/jkns.2012.52.3.221
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Rights and permissions
About this article
Cite this article
Yousef, A., Rutkowski, M.J., Yalcin, C.E. et al. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences. J Neurooncol 143, 547–552 (2019). https://doi.org/10.1007/s11060-019-03189-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-019-03189-w